We employed TargetScan [27] to define putative miR binding sites on the 3′UTR of IL13RA1. Amongst miRs identified to potentially target IL13RA1, we selected a subset previously reported to be dysregulated in inflammatory bowel disease (Figure 2a and Table S1): miR-155-5p [28,29], miR-31-5p [28,30], miR-183-5p [28] and miR-324-3p [30]. The gene discussed is IL13RA1; the disease is inflammatory bowel disease.